Suppr超能文献

表皮生长因子受体表达可预测猫皮肤鳞状细胞癌的不良预后。

Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma.

作者信息

Sabattini Silvia, Marconato Laura, Zoff Aurora, Morini Maria, Scarpa Filippo, Capitani Ombretta, Bettini Giuliano

机构信息

Department of Veterinary Public Health and Animal Pathology, Alma Mater Studiorum, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano dell'Emilia, Bologna, Italy.

出版信息

J Feline Med Surg. 2010 Oct;12(10):760-8. doi: 10.1016/j.jfms.2010.04.010. Epub 2010 Jul 31.

Abstract

The aim of this study was to investigate epidermal growth factor receptor (EGFR) expression in feline cutaneous squamous cell carcinoma (FC-SCC) and assess its prognostic role. Nineteen formalin-fixed paraffin-embedded excisional biopsies of FC-SCC were tested for EGFR expression using immunohistochemistry (IHC). Relationships between EGFR expression and histopathological parameters (differentiation, mitotic activity), disease-free interval (DFI) and overall survival (OS) at 24 months were further investigated. Fourteen of 19 tumours (73.7%) were positive for EGFR, with great variation in intensity and proportion of labelled cells. EGFR expression was not correlated with tumour differentiation or mitotic activity. Nine cats (47.4%) died of tumour-related causes. Patients with EGFR-positive tumours had a significantly worse outcome (P=0.0217), with decreased DFIs (P=0.0075) and survival times (P=0.0391). These data suggest that EGFR expression carries a negative prognostic significance in FC-SCC. EGFR inhibitors in association with conventional treatments may improve outcome for the subgroup of cats with EGFR-positive tumours.

摘要

本研究旨在调查猫皮肤鳞状细胞癌(FC-SCC)中表皮生长因子受体(EGFR)的表达情况,并评估其预后作用。使用免疫组织化学(IHC)对19例FC-SCC的福尔马林固定石蜡包埋切除活检组织进行EGFR表达检测。进一步研究EGFR表达与组织病理学参数(分化程度、有丝分裂活性)、无病间期(DFI)以及24个月总生存期(OS)之间的关系。19个肿瘤中有14个(73.7%)EGFR呈阳性,标记细胞的强度和比例差异很大。EGFR表达与肿瘤分化程度或有丝分裂活性无关。9只猫(47.4%)死于肿瘤相关原因。EGFR阳性肿瘤患者的预后明显较差(P=0.0217),DFI降低(P=0.0075),生存时间缩短(P=0.0391)。这些数据表明,EGFR表达在FC-SCC中具有负面预后意义。EGFR抑制剂与传统治疗联合使用可能会改善EGFR阳性肿瘤猫亚组的预后。

相似文献

1
Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma.
J Feline Med Surg. 2010 Oct;12(10):760-8. doi: 10.1016/j.jfms.2010.04.010. Epub 2010 Jul 31.
2
Immunohistochemical detection of COX-2 in feline and canine actinic keratoses and cutaneous squamous cell carcinoma.
J Comp Pathol. 2012 Jan;146(1):11-7. doi: 10.1016/j.jcpa.2011.03.012. Epub 2011 May 24.
4
Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC).
Vet Comp Oncol. 2011 Jun;9(2):106-17. doi: 10.1111/j.1476-5829.2010.00239.x. Epub 2010 Sep 2.
6
EGFR expression in advanced head and neck cutaneous squamous cell carcinoma.
Head Neck. 2012 May;34(5):681-6. doi: 10.1002/hed.21802. Epub 2011 Jul 7.
7
Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase.
Vet Comp Oncol. 2016 Dec;14(4):371-383. doi: 10.1111/vco.12117. Epub 2014 Sep 11.
9
Clinical features and outcomes of Merkel cell carcinoma in 20 cats.
Vet Comp Oncol. 2018 Dec;16(4):554-561. doi: 10.1111/vco.12414. Epub 2018 Jul 18.

引用本文的文献

1
A Scoping Review on Tyrosine Kinase Inhibitors in Cats: Current Evidence and Future Directions.
Animals (Basel). 2023 Sep 29;13(19):3059. doi: 10.3390/ani13193059.
2
Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma.
Front Vet Sci. 2023 May 17;10:1079019. doi: 10.3389/fvets.2023.1079019. eCollection 2023.
3
Nanobody-targeted photodynamic therapy for the treatment of feline oral carcinoma: a step towards translation to the veterinary clinic.
Nanophotonics. 2021 Aug 2;10(12):3075-3087. doi: 10.1515/nanoph-2021-0195. eCollection 2021 Sep.
4
miR-27a Downregulation Promotes Cutaneous Squamous Cell Carcinoma Progression via Targeting EGFR.
Front Oncol. 2020 Jan 21;9:1565. doi: 10.3389/fonc.2019.01565. eCollection 2019.
6
Elevated EGF Levels in the Blood Serum of Dogs with Periodontal Diseases and Oral Tumours.
In Vivo. 2018 May-Jun;32(3):507-515. doi: 10.21873/invivo.11268.
7
Cats, Cancer and Comparative Oncology.
Vet Sci. 2015 Jun 30;2(3):111-126. doi: 10.3390/vetsci2030111.
9
Electroporation Enhances Bleomycin Efficacy in Cats with Periocular Carcinoma and Advanced Squamous Cell Carcinoma of the Head.
J Vet Intern Med. 2015 Sep-Oct;29(5):1368-75. doi: 10.1111/jvim.13586. Epub 2015 Jul 20.

本文引用的文献

1
EGFR signaling and drug discovery.
Oncology. 2009;77(6):400-10. doi: 10.1159/000279388. Epub 2010 Feb 2.
2
Epidermal growth factor receptor expression in feline oral squamous cell carcinomas.
Vet Comp Oncol. 2006 Mar;4(1):33-40. doi: 10.1111/j.1476-5810.2006.00091.x.
5
Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.
Cancer Sci. 2008 Aug;99(8):1589-94. doi: 10.1111/j.1349-7006.2008.00861.x.
6
Tyrosine kinase activating mutations in human malignancies: implications for diagnostic pathology.
Exp Mol Pathol. 2008 Aug;85(1):68-75. doi: 10.1016/j.yexmp.2008.03.010. Epub 2008 Apr 10.
7
Aberrant kinase signaling: lessons from head and neck cancer.
Future Oncol. 2007 Jun;3(3):353-61. doi: 10.2217/14796694.3.3.353.
8
Expression of protein tyrosine kinases in head and neck squamous cell carcinomas.
Am J Clin Pathol. 2005 Jul;124(1):71-6. doi: 10.1309/BTLN5WTMJ3PCNRRC.
9
Epidermal growth factor receptor inhibition strategies in oncology.
Endocr Relat Cancer. 2004 Dec;11(4):689-708. doi: 10.1677/erc.1.00600.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验